| Dr Clayton Thomas Bauer, MD/PHD | |
|
13837 Circa Crossing Dr, Lithia, FL 33547-4382 | |
| (813) 684-2663 | |
| (813) 658-6222 |
| Full Name | Dr Clayton Thomas Bauer |
|---|---|
| Gender | Male |
| Speciality | Neurosurgery |
| Experience | 9 Years |
| Location | 13837 Circa Crossing Dr, Lithia, Florida |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1639564842 | NPI | - | NPPES |
| 113226300 | Medicaid | FL |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207T00000X | Neurological Surgery | ME154673 (Florida) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Adventhealth Tampa | Tampa, FL | Hospital |
| South Florida Baptist Hospital | Plant city, FL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Sports And Orthopedic Rehabilitation Services Inc | 0840104253 | 192 |
| Orthopaedic Medical Group Of Tampa Bay Pa | 9436220415 | 32 |
News Archive
Genzyme Corp. announced today that the European Medicines Agency (EMEA) has accepted its marketing authorization application for Myozyme(R) (alglucosidase alfa), an investigational enzyme replacement therapy for Pompe disease.
Biosense Webster, Inc., a worldwide leader in the diagnosis and treatment of cardiac arrhythmias, announced today that the U.S. Food and Drug Administration (FDA) has cleared for marketing the CARTOXPRESS™ Software Module and the LASSO® NAV Circular Mapping Catheter for use with the CARTO® XP Mapping System.
Severely obese patients who had Roux-en-Y gastric bypass surgery had significant weight loss that was sustained for an average of 6 years after the surgery and also experienced frequent remission and lower incidence of diabetes, hypertension, and abnormal cholesterol levels, compared to participants who did not have the surgery, according to a study in the September 19 issue of JAMA, and theme issue on obesity.
University of Massachusetts Amherst biophysicist Jenny Ross has won one of the top national honors in her field, the 2013 Margaret Oakley Dayhoff Award, from the Biophysical Society of Rockville, Md. It is given to a woman who has achieved prominence for "substantial contributions to science," while showing very high promise for ideas and leadership in the early stages of her biophysical research career.
› Verified 5 days ago
| Entity Name | Orthopaedic Medical Group Of Tampa Bay Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1740407121 PECOS PAC ID: 9436220415 Enrollment ID: O20080618000714 |
News Archive
Genzyme Corp. announced today that the European Medicines Agency (EMEA) has accepted its marketing authorization application for Myozyme(R) (alglucosidase alfa), an investigational enzyme replacement therapy for Pompe disease.
Biosense Webster, Inc., a worldwide leader in the diagnosis and treatment of cardiac arrhythmias, announced today that the U.S. Food and Drug Administration (FDA) has cleared for marketing the CARTOXPRESS™ Software Module and the LASSO® NAV Circular Mapping Catheter for use with the CARTO® XP Mapping System.
Severely obese patients who had Roux-en-Y gastric bypass surgery had significant weight loss that was sustained for an average of 6 years after the surgery and also experienced frequent remission and lower incidence of diabetes, hypertension, and abnormal cholesterol levels, compared to participants who did not have the surgery, according to a study in the September 19 issue of JAMA, and theme issue on obesity.
University of Massachusetts Amherst biophysicist Jenny Ross has won one of the top national honors in her field, the 2013 Margaret Oakley Dayhoff Award, from the Biophysical Society of Rockville, Md. It is given to a woman who has achieved prominence for "substantial contributions to science," while showing very high promise for ideas and leadership in the early stages of her biophysical research career.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Clayton Thomas Bauer, MD/PHD 13837 Circa Crossing Dr, Lithia, FL 33547-4382 Ph: (813) 684-2663 | Dr Clayton Thomas Bauer, MD/PHD 13837 Circa Crossing Dr, Lithia, FL 33547-4382 Ph: (813) 684-2663 |
News Archive
Genzyme Corp. announced today that the European Medicines Agency (EMEA) has accepted its marketing authorization application for Myozyme(R) (alglucosidase alfa), an investigational enzyme replacement therapy for Pompe disease.
Biosense Webster, Inc., a worldwide leader in the diagnosis and treatment of cardiac arrhythmias, announced today that the U.S. Food and Drug Administration (FDA) has cleared for marketing the CARTOXPRESS™ Software Module and the LASSO® NAV Circular Mapping Catheter for use with the CARTO® XP Mapping System.
Severely obese patients who had Roux-en-Y gastric bypass surgery had significant weight loss that was sustained for an average of 6 years after the surgery and also experienced frequent remission and lower incidence of diabetes, hypertension, and abnormal cholesterol levels, compared to participants who did not have the surgery, according to a study in the September 19 issue of JAMA, and theme issue on obesity.
University of Massachusetts Amherst biophysicist Jenny Ross has won one of the top national honors in her field, the 2013 Margaret Oakley Dayhoff Award, from the Biophysical Society of Rockville, Md. It is given to a woman who has achieved prominence for "substantial contributions to science," while showing very high promise for ideas and leadership in the early stages of her biophysical research career.
› Verified 5 days ago